Pharmaceutical Manufacturer Agrees to Pay $3.6 Million to Resolve Improper Marketing Allegations May 16, 2025 Share this: facebook twitter linkedin ARTICLE TAGS Fraud and Compliance You must be logged in to access this content. Log in